Lauren Sabella
Geschäftsführer bei MANNKIND CORPORATION
Vermögen: 2 Mio $ am 30.04.2024
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Kerry Clem | M | 54 | 13 Jahre | |
| James Shannon | M | 68 | 9 Jahre | |
| Burkhard Blank | M | 69 |
Altus Pharmaceuticals, Inc.
 Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | 11 Jahre |
| Kent Kresa | M | 86 | 20 Jahre | |
| Steven Binder | M | 61 | 7 Jahre | |
| Michael Castagna | M | 47 | 8 Jahre | |
| Rosabel Realica Alinaya | F | 63 | 21 Jahre | |
| Michael Gesser | M | 61 | 3 Jahre | |
| Neil Belloff | M | 64 | 3 Jahre | |
| David Thomson | M | 57 | 22 Jahre | |
| Christine Mundkur | F | 55 | 6 Jahre | |
| Anthony Hooper | M | 69 | 4 Jahre | |
| Sabrina Kay | M | 61 | 4 Jahre | |
| Jennifer Grancio | F | 52 | 4 Jahre | |
| Michael Friedman | M | 80 | 21 Jahre | |
| John Varian | M | 64 | 2 Jahre | |
| Peder Jensen | M | 69 | 13 Jahre | |
| Ronald Consiglio | M | 80 | 21 Jahre | |
| Karen Jaffe | F | - | 4 Jahre | |
| Joseph Kocinsky | M | 60 | 21 Jahre | |
| Stuart Tross | M | 57 | 8 Jahre | |
| Kevin Kaiserman | M | - | 4 Jahre | |
| Sanjay Singh | M | 57 | 2 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Georges Gemayel | M | 63 |
Altus Pharmaceuticals, Inc.
Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | 1 Jahre |
| Sheldon Berkle | M | 78 |
Altus Pharmaceuticals, Inc.
Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA.
Boehringer Ingelheim Pharmaceuticals, Inc.
 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | 13 Jahre |
| Robert Morales | M | 57 | 7 Jahre | |
| Adrian L. Rabinowicz | M | - | 6 Jahre | |
| Bruce A. Leicher | M | 68 |
Altus Pharmaceuticals, Inc.
Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | 2 Jahre |
| Barry Greene | M | 60 | 14 Jahre | |
| David D. Pendergast | M | 76 |
Altus Pharmaceuticals, Inc.
Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | - |
| Ian Smith | M | 58 | 12 Jahre | |
| Catherine D. Strader | M | 70 | 4 Jahre | |
| Jane Wasman | F | 67 | 15 Jahre | |
| Kent Rogers | M | 54 | - | |
| Steven M. Rauscher | M | 70 | 15 Jahre | |
| Soon H. Lee | M | - | - | |
| Douglas Kargman | M | - | - | |
| Jennifer Burstein | F | 52 | 9 Jahre | |
| Andrew Hindman | M | 51 | 5 Jahre | |
| Enrique Carrazana | M | 62 | 5 Jahre | |
| Brian W. Hutchinson | M | - | 5 Jahre | |
| Elizabeth Keating | F | - | - | |
| Anthony Caggiano | M | 54 | 16 Jahre | |
| Thomas C. Aquilina | M | - | - | |
| Todd F. Baumgartner | M | - | 5 Jahre | |
| Rebecca R. Levine | F | - | 5 Jahre | |
| Peter Carbone | M | - | - | |
| Michael Samar | M | 51 | 3 Jahre | |
| Erin Campany | F | 57 | 4 Jahre | |
| Ruhi Khan | F | 49 | 5 Jahre | |
| S. Michael Imperiale | M | - |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | 4 Jahre |
| Thomas Hofmann | M | - | 4 Jahre | |
| Alexey L. Margolin | M | 71 |
Altus Pharmaceuticals, Inc.
Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | 14 Jahre |
| Dean N. DiMaria | M | 62 |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | 10 Jahre |
| Philip Gotwals | M | 61 |
Altus Pharmaceuticals, Inc.
Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | 3 Jahre |
| Lynne Brum | F | 60 |
Altus Pharmaceuticals, Inc.
Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | - |
| John M. Sorvillo | M | 69 |
Altus Pharmaceuticals, Inc.
Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | 3 Jahre |
| Michael Rogers | M | 64 | 3 Jahre | |
| Renato Fuchs | M | 80 |
Altus Pharmaceuticals, Inc.
Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | 1 Jahre |
| Wise Young | M | 74 | 16 Jahre | |
| Kenneth Attie | M | 67 |
Altus Pharmaceuticals, Inc.
Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | 2 Jahre |
| Herbert Raymond Henney | M | - | 9 Jahre | |
| Robert Gallotto | M | 59 |
Altus Pharmaceuticals, Inc.
Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | 7 Jahre |
| Richard Batycky | M | 56 | - | |
| Martin Freed | M | 63 | 1 Jahre | |
| Thomas C. Wessel | M | 68 | 3 Jahre | |
| Benedict Osorio | M | 67 | 2 Jahre | |
| Mikael Dolsten | M | 65 |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | 5 Jahre |
| Raymond E. Stoll | M | - |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | - |
| Christopher Kenney | M | 53 | 3 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 70 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Lauren Sabella
- Persönliches Netzwerk
